Overview An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis Status: Recruiting Trial end date: 2023-09-01 Target enrollment: Participant gender: Summary Phase 2 study of RPT193 in adults with atopic dermatitis Phase: Phase 2 Details Lead Sponsor: RAPT Therapeutics, Inc.